2025

First blood biomarker developed in Catalonia to predict progression from mild cognitive impairment to Alzheimer’s dementia

IDIBELL and the Bellvitge University Hospital have played a key role in the clinical validation of a new blood biomarker discovered and developed in Catalonia which, for the first time, makes it possible to predict the progression from mild cognitive impairment (MCI) to Alzheimer’s dementia. While recently developed international blood biomarkers can confirm the presence

First blood biomarker developed in Catalonia to predict progression from mild cognitive impairment to Alzheimer’s dementia Read More »

Researchers from CIC and IDIBELL propose new therapeutic approaches for cholangiocarcinoma, a cancer with a poor prognosis

A team from the Cancer Research Centre (University of Salamanca-CSIC), led by Javier Vaquero, and other from IDIBELL, led by Isabel Fabregat, have developed a key study published in the journal Signal transduction and targeted therapy that proposes an innovative strategy to slow the growth of cholangiocarcinoma, a type of liver cancer with a poor prognosis. The work on intrahepatic cholangiocarcinoma identifies a new therapeutic target that allows tumour progression to be blocked in a specific way and with fewer side effects. The research results are a milestone in understanding the mechanisms that regulate tumor growth in cholangiocarcinoma and provide a solid foundation for the development of future more effective and safer therapies.

Researchers from CIC and IDIBELL propose new therapeutic approaches for cholangiocarcinoma, a cancer with a poor prognosis Read More »

A new marker of good prognosis in metastatic uveal melanoma has been identified

IDIBELL-ICO researchers propose a new favourable prognostic marker in metastatic uveal melanoma that could serve to clarify the prognostic outlook of patients with metastasis.

A new marker of good prognosis in metastatic uveal melanoma has been identified Read More »

The risk of developing diabetes is reduced with the combination of Mediterranean diet and physical activity

The combination of a low-calorie Mediterranean diet and physical activity can help prevent new cases of type II diabetes.

The risk of developing diabetes is reduced with the combination of Mediterranean diet and physical activity Read More »

Brisk walking or dancing 20 minutes a day reduces the risk of starting treatment with psychotropic drugs in older people

Following a Mediterranean diet and exercising can help prevent psychotropic drug treatment in older adults.

Brisk walking or dancing 20 minutes a day reduces the risk of starting treatment with psychotropic drugs in older people Read More »

A clinical trial with the participation of HUB and IDIBELL proposes alternatives to the treatment of resistant depression

Switching antidepressants or combining it with psychotherapy is more effective than increasing the dose in treatment-resistant patients with major depression.

A clinical trial with the participation of HUB and IDIBELL proposes alternatives to the treatment of resistant depression Read More »

Advances in precision oncology and hereditary cancer: researchers describe the clinical and molecular impact of mutations in key genes for DNA replication and repair

IDIBELL researchers have conducted an in-depth characterization of all known pathogenic variants in the POLE and POLD1 genes, which are essential for DNA repair and replication.

Advances in precision oncology and hereditary cancer: researchers describe the clinical and molecular impact of mutations in key genes for DNA replication and repair Read More »

25 years of the Human Genome: AI and biological chemistry break in to help decode the secrets of the genome

A global initiative has been launched to help understand the genome with the help of AI and biological chemistry, and thus facilitate drug discovery.

25 years of the Human Genome: AI and biological chemistry break in to help decode the secrets of the genome Read More »

Food addiction does not prevent the success of bariatric surgery, but it can increase the risk of weight regain

Food addiction is not a barrier to achieving significant weight loss, but it can increase the risk of regaining weight over the years.

Food addiction does not prevent the success of bariatric surgery, but it can increase the risk of weight regain Read More »

Scroll to Top